SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation

被引：0
|
作者：
Yehong Bin
Dong Lan
Wenguang Bao
Haiyan Yang
Shengsheng Zhou
Fengxiang Huang
Man Wang
Zhigang Peng
机构：
[1] the First Affiliated Hospital of Guangxi Medical University,Department of Oncology
来源：
Trials | / 23卷
关键词：
Advanced gastric cancer; Malignant ascites; Intraperitoneal infusion of chemotherapy; First-line chemotherapy; Docetaxel; S-1; Oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation
    Bin, Yehong
    Lan, Dong
    Bao, Wenguang
    Yang, Haiyan
    Zhou, Shengsheng
    Huang, Fengxiang
    Wang, Man
    Peng, Zhigang
    TRIALS, 2022, 23 (01)
  • [2] Camrelizumab combined with SOX regimen in the first-line treatment of unresectable advanced or recurrent gastric cancer: A single-arm, prospective, open clinical study.
    Han, Zhengxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Efficacy and safety of SOX regimen combined with inetetamab as first-line treatment for HER2-positive advanced gastric cancer.
    Kong, Ying
    Dong, Qi
    Jin, Peng
    Li, Yan Ming
    Ma, Li
    Liu, Yan Hai
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Updated efficacy and safety of SOX regimen combined with inetetamab as first-line treatment for HER2-positive advanced gastric cancer
    Kong, Y.
    Dong, Q.
    Jin, P.
    Li, M.
    Ma, L.
    Yi, Q.
    Miao, Y-E.
    Liu, J.
    Liu, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1467 - S1467
  • [5] Retrospective analysis of docetaxel, oxaliplatin plus fluorouracil compared with epirubicin, cisplatin and fluorouracil as first-line therapy for advanced gastric cancer
    Yao, Zhihua
    Guo, Hongqiang
    Yuan, Yadong
    Zhao, Yan
    Yao, Shuna
    Xu, Yingjun
    Liu, Lei
    Liu, Tao
    Liu, Yanyan
    Yang, Shujun
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (02) : 117 - 121
  • [6] A RETROSPECTIVE ANALYSIS OF PACLITAXEL (ALBUMIN BINDING TYPE) COMBINED WITH S-1 COMPARED WITH SOX REGIMEN AS FIRST-LINE TREATMENT FOR LAUREN DIFFUSE TYPE ADVANCED GASTRIC CANCER
    Hua, Yunqi
    Wang, Chenlin
    Zhao, Meili
    Cao, Kun
    Li, Xi
    Li, Jie
    GUT, 2021, 70 : A136 - A136
  • [7] Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
    Jinwan Wang
    Ruihua Xu
    Jian Li
    Yuxian Bai
    Tianshu Liu
    Shunchang Jiao
    Guanghai Dai
    Jianming Xu
    Yunpeng Liu
    Nanfeng Fan
    Yongqian Shu
    Yi Ba
    Dong Ma
    Shukui Qin
    Leizhen Zheng
    Weichang Chen
    Lin Shen
    Gastric Cancer, 2016, 19 : 234 - 244
  • [8] Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
    Wang, Jinwan
    Xu, Ruihua
    Li, Jian
    Bai, Yuxian
    Liu, Tianshu
    Jiao, Shunchang
    Dai, Guanghai
    Xu, Jianming
    Liu, Yunpeng
    Fan, Nanfeng
    Shu, Yongqian
    Ba, Yi
    Ma, Dong
    Qin, Shukui
    Zheng, Leizhen
    Chen, Weichang
    Shen, Lin
    GASTRIC CANCER, 2016, 19 (01) : 234 - 244
  • [9] DOCETAXEL, CISPLATIN, 5-FLUOROURACIL AND LEUCOVORIN AS FIRST-LINE THERAPY IN ADVANCED GASTRIC CANCER (AGC)
    Trusilova, E.
    Besova, N.
    Gorbunova, V. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 250 - 251
  • [10] Phase II study of oxaliplatin combined with S-1 (SOX) as first-line therapy for patients with advanced gastric cancer (AGC)
    Takiuchi, H.
    Koizumi, W.
    Yamada, Y.
    Boku, N.
    Komatsu, Y.
    Fuse, N.
    Muro, K.
    Tsuburaya, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345